Dyskinesia induced by phenytoin

Arquivos de Neuro-Psiquiatria

Volumn 57, Issue 2 B, 1999, Pages 356-360

  Montenegro, M Augusta ^b   Scotoni, Anna Elisa ^b   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

Dyskinesia; Involuntary movement; Phenytoin

Indexed keywords

PHENYTOIN;

ARTICLE; CHILD; CHOREOATHETOSIS; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSKINESIA; HUMAN; INVOLUNTARY MOVEMENT; TREATMENT PLANNING;

EID: 0033016443     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1999000300002     Document Type: Article

References (42)

1. Wilder HJ. Phenytoin: clinical use. In Levy RH, Mattson RH. Meldrum BS (eds). Antiepileptic drugs. 4.Ed. New York; Raven Press, 1995;339-344.
2. Bruni J. Toxicity. In Levy RH, Mattson RH, Meldrum BS (eds). Antiepileptic drugs. 4.Ed. New York; Raven Press, 1995;345-350.
3. Ahmad S, Laidlaw J, Houghton GW, Richens A. Involuntary movements caused by phenytoin intoxication in epileptic patients. J Neurol Neurosurg Psychiatry 1975;38:225-231.
4. Bellman MH , Haas L, Toxic reaction to phenytoin, Br Med J 1974;2:256-257.
5. Buchanan N, Rosen E, Rabinowtz L. Athetosis and phenytoin toxicity. Am J Dis Child 1977; 131: 105-106.
6. Chadwik D, Reynolds EH, Marsden CD. Anticonvulsivanls-induced dyskinesias: a comparison with dyskinestas induced by neuroleptics. J Neurol Neurosurg Psychiatry 1976;39:1210-1218.
7. Chalhub RG, DeVivo DC. Volpe JJ. Phenytoin-induced dystonia and choreoathelosis in two retarded epileptic children. Neurology 1976;26:494-498.
8. Choonara IA, Rosenbloom L, Focal dystonic reaction to phenytoin. Dev Med Child Neurol 1984;26:677-680.
9. Corey A, Koller W. Phenytoin induced dystonia. Ann Neurol 1983;14:92-93.
10. Crosley CJ, Swender PT. Dystonia associated with carbamazepine administration: experience in brain damage children. Pediatrics 1979; 63: 612-615.
11. DeVeaugh-Geiss J. Aggravation of tardive dyskinesia by phenytoin. N Engl J Med 1978;298:457-458.
12. Diehl L. Nil nocere! Ungewohnliche hyperkinetische Syndrome nach Diphenylhydantoin- Medikation. Munchen Med Wochenschr 1969;3:1679-1681.
13. Fillousx F, Thompson J A. Transient chorea induced by phenytoin. Pediatr 1987;110:639-641.
14. Gerber N, Lyun R, Oates J. Acute intoxication with 5,5-diphenylhydantoin (dilamin) associated with impairment of biotransformation. Ann Intern Med 1972;77:765-771.
15. Harrison M B, Lyons G R, Landow E R. Phenytoin and dyskinesias: a report of two cases and review of the literature. Mov Disord 1993;8:19-27.
16. Hoaken PCS, Francis JK Jr. Unusual brain syndrome seen with diphenylhydantoin and pentobarbital. Am J Psychiatry 1963;120:282-283.
17. Howrie DL, Crumrine PK. Phenytoin-Induced movement disorder associated with intravenous administration for status epileplicus. Clin Pediatr 1985;24:467-469.
18. Kirschberg GJ. Dyskinesia: a usual reaction to ethosuximide Arch Neurol 1975;32:137-138.
19. Kooiker JC, Sumi SM. Movement disorder as a manifestation of diphenylhydantoin intoxication. Neurology 1974;24:68-71.
20. Krishnamoorthy KS, Zalneraitis LL, Young RSK, Bernard PG. Phenytoin-induced choroathetosis in infancy: case report and a review. Pediatrics 1983,72:831-834.
21. Kurata K, Kido H, Kobayashi K, Yamaguchi N. Long-lasting movement disorder induced by intravenous phenytoin administration for status epilepticus: a case report. Clin Neuropharmacol 1988:11:467-471.
22. Lalonde R. Dopaminergic supersensitivity after long-term administration of phenytoin in rats: Epilepsia 1985;26:81-84.
23. Lazaro R P. Involuntary movements induced by anticonvulsivant drugs. Mt Sinai J Med 1982;49:274-281.
24. Logan WJ, Freeman JM. Pseudodegenerative disease due to diphenylhydantoin intoxication. Arch Neurol 1969;21:631-637.
25. Lundorf K, Lund M. Phenytoin-induced hyperkinesia. Epilepsia 1977;18:409-415.
26. Mauguirere F, Dalery J. deVillard R et al. Transient hyperkinesia after a single intravenous perfusion of diphenylhydantoin. Eur Neurol 1979;18:116-123.
27. McLellan DL, Swash M. Choreoathetosis and encephlopathy induced by phenytoin. Br Med J 1974;2:204-205.
28. Micheli F, Lehkuniec E, Gatto M, Pelli M, Asconape J. Hemiballism in a patient with partial motor status epilepticus treated with phenytoin. Func Neurol 1993;8:103-107.
29. Moss W, Ojukwu C, Chiriboga CA. Phenytoin-induced movement disorder: unilateral presentation in a child and response to diphenhydramine. Clin Pediatr 1994;33:634-636.
30. Nausieda PA, Koller WC, Wiener WJ. et al. Clinical and experimental studies of phenytoin-induced hyperkinesia. J Neural Transm 1979;45:291-305.
31. Opida CL , Korthals JK. Somasundaram M. Bilateral balismus in phenytoin intoxication. Ann Neurol 1978;3:186.
32. Peters HA, Eichman PL , Price JM et al. Abnormal copper and tryptophan metabolism and chelation therapy in anticonvulsant drug intolerance. Dis Nerv Syst 1966;28:97-107.
33. Rasmusen S, Kristensen M. Choreoathelosis during phenytoin treatment. Acta Med Scand 1977;201:239-241.
34. Reimer E, Christini K. Motorische Reizerscheinungen nach Diphenyl-hydantointoxikation. Nervenartz 1967;38:509-615.
35. Reynolds EH, Trimble MR. Adverse neuropsychiatric effects of anticonvulsivant drugs. Drugs 1985;29:570-581.
36. Rosenblum E, Rodichok L, Hanson PA, et al. Movement disorder as a manifestation of diphenylhydantoin toxicity. Pediatrics 1974;54:364-366.
37. Shulman L M, Singer C, Weiner W J. Rhenytoin-induced focal crorea. Mov Disord 1996;11:111-114.
38. Shuttleworth E, Wise G, Paulson G. Choreoathetosis and diphenylhydantoin intoxication. JAMA 1974;230:1170-1171.
39. Tomson T. Choreoathetosis induced by ordinary phenytoin levels, explained by high free fraction? A case report. Ther Drug Monit 1988;10:139-241.
40. Joyce RP, Gunderson CH. Carbamazepine-induced orofacial dyskinesia. Neurology 1980;30:1333-1334.
41. Wiznitzer M, Yiunkin D. Phenobarbital-induced dyskinesia in a neurology-impaired child. Neurology 1984;34:1600-1601.
42. Hulley SB, Cummings SR. Designing in clinical research. Baltimore. Williams & Wilkins 1988.